Related Experiment Video
Updated: Jul 12, 2025

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
Advancements in CRISPR screens for the development of cancer immunotherapy strategies
Yan-Ruide Li1, Zibai Lyu1, Yanxin Tian1
1Department of Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Abstract:
CRISPR screen technology enables systematic and scalable interrogation of gene function by using the CRISPR-Cas9 system to perturb gene expression. In the field of cancer immunotherapy, this technology has empowered the discovery of genes, biomarkers, and pathways that regulate tumor development and progression, immune reactivity, and the effectiveness of immunotherapeutic interventions. By conducting large-scale genetic screens, researchers have successfully identified novel targets to impede tumor growth, enhance anti-tumor immune responses, and surmount immunosuppression within the tumor microenvironment (TME). Here, we present an overview of CRISPR screens conducted in tumor cells for the purpose of identifying novel therapeutic targets. We also explore the application of CRISPR screens in immune cells to propel the advancement of cell-based therapies, encompassing T cells, natural killer cells, dendritic cells, and macrophages. Furthermore, we outline the crucial components necessary for the successful implementation of immune-specific CRISPR screens and explore potential directions for future research.
Insights
CRISPR screens are revolutionizing cancer immunotherapy by identifying new targets in tumor and immune cells. This technology enhances anti-tumor immunity and advances cell-based therapies for better cancer treatment.
Area of Science:
- Genomics and Molecular Biology
- Cancer Research
- Immunology
Background:
- CRISPR-Cas9 technology allows for systematic gene function studies.
- Cancer immunotherapy relies on understanding tumor-immune interactions and therapeutic targets.
- CRISPR screens have emerged as powerful tools in cancer research.
Purpose of the Study:
- To provide an overview of CRISPR screens in tumor cells for novel therapeutic target discovery.
- To explore CRISPR screens in immune cells for advancing cell-based therapies.
- To outline key components and future directions for immune-specific CRISPR screens.
Main Methods:
- Large-scale genetic screens using the CRISPR-Cas9 system.
- Application of CRISPR screens in both tumor cells and various immune cells (T cells, NK cells, dendritic cells, macrophages).
- Analysis of gene function, biomarkers, and pathways regulating tumor immunity.
Main Results:
- Identification of novel targets to inhibit tumor growth and enhance anti-tumor immune responses.
- Discovery of genes and pathways crucial for overcoming immunosuppression in the tumor microenvironment (TME).
- Advancement of cell-based immunotherapies through insights gained from immune cell CRISPR screens.
Conclusions:
- CRISPR screens are instrumental in discovering therapeutic targets for cancer immunotherapy.
- The technology significantly contributes to understanding and improving anti-tumor immunity.
- Future research directions focus on optimizing immune-specific CRISPR screens for enhanced therapeutic strategies.
Related Concept Videos
Tumor Immunotherapy
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
CRISPR
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
CRISPR/Cas9 Genome Editing

